Literature DB >> 25367975

The spectrum of fungi that infects humans.

Julia R Köhler1, Arturo Casadevall2, John Perfect3.   

Abstract

Few among the millions of fungal species fulfill four basic conditions necessary to infect humans: high temperature tolerance, ability to invade the human host, lysis and absorption of human tissue, and resistance to the human immune system. In previously healthy individuals, invasive fungal disease is rare because animals' sophisticated immune systems evolved in constant response to fungal challenges. In contrast, fungal diseases occur frequently in immunocompromised patients. Paradoxically, successes of modern medicine have put increasing numbers of patients at risk for invasive fungal infections. Uncontrolled HIV infection additionally makes millions vulnerable to lethal fungal diseases. A concerted scientific and social effort is needed to meet these challenges.
Copyright © 2015 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25367975      PMCID: PMC4292074          DOI: 10.1101/cshperspect.a019273

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  230 in total

1.  Induction of mating in Candida albicans by construction of MTLa and MTLalpha strains.

Authors:  B B Magee; P T Magee
Journal:  Science       Date:  2000-07-14       Impact factor: 47.728

Review 2.  The distinct morphogenic states of Candida albicans.

Authors:  Peter Sudbery; Neil Gow; Judith Berman
Journal:  Trends Microbiol       Date:  2004-07       Impact factor: 17.079

3.  A major role for capsule-independent phagocytosis-inhibitory mechanisms in mammalian infection by Cryptococcus neoformans.

Authors:  Cheryl D Chun; Jessica C S Brown; Hiten D Madhani
Journal:  Cell Host Microbe       Date:  2011-03-17       Impact factor: 21.023

4.  Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1.

Authors:  J F Staab; S D Bradway; P L Fidel; P Sundstrom
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

5.  Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies.

Authors:  J R Boelaert; M de Locht; J Van Cutsem; V Kerrels; B Cantinieaux; A Verdonck; H W Van Landuyt; Y J Schneider
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

6.  A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease.

Authors:  Tran Th Chau; Nguyen H Mai; Nguyen H Phu; Ho D Nghia; Ly V Chuong; Dinh X Sinh; Van A Duong; Pham T Diep; James I Campbell; Stephen Baker; Tran T Hien; David G Lalloo; Jeremy J Farrar; Jeremy N Day
Journal:  BMC Infect Dis       Date:  2010-07-09       Impact factor: 3.090

Review 7.  Discovering the secrets of the Candida albicans agglutinin-like sequence (ALS) gene family--a sticky pursuit.

Authors:  Lois L Hoyer; Clayton B Green; Soon-Hwan Oh; Xiaomin Zhao
Journal:  Med Mycol       Date:  2008-02       Impact factor: 4.076

8.  Temperature-induced switch to the pathogenic yeast form of Histoplasma capsulatum requires Ryp1, a conserved transcriptional regulator.

Authors:  Van Q Nguyen; Anita Sil
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-13       Impact factor: 11.205

9.  Host switching promotes diversity in host-specialized mycoparasitic fungi: uncoupled evolution in the Biatoropsis-usnea system.

Authors:  Ana M Millanes; Camille Truong; Martin Westberg; Paul Diederich; Mats Wedin
Journal:  Evolution       Date:  2014-03-04       Impact factor: 3.694

10.  Cryptococcosis in domestic animals in Western Australia: a retrospective study from 1995-2006.

Authors:  S McGill; R Malik; N Saul; S Beetson; C Secombe; I Robertson; P Irwin
Journal:  Med Mycol       Date:  2009       Impact factor: 4.076

View more
  58 in total

1.  Transcription factor network efficiency in the regulation of Candida albicans biofilms: it is a small world.

Authors:  Virginia E Glazier; Damian J Krysan
Journal:  Curr Genet       Date:  2018-01-09       Impact factor: 3.886

2.  Human fungal pathogens: Why should we learn?

Authors:  Jeong-Yoon Kim
Journal:  J Microbiol       Date:  2016-03       Impact factor: 3.422

Review 3.  Fungal infections in animals: a patchwork of different situations.

Authors:  Seyedmojtaba Seyedmousavi; Sandra de M G Bosco; Sybren de Hoog; Frank Ebel; Daniel Elad; Renata R Gomes; Ilse D Jacobsen; Henrik Elvang Jensen; An Martel; Bernard Mignon; Frank Pasmans; Elena Piecková; Anderson Messias Rodrigues; Karuna Singh; Vania A Vicente; Gudrun Wibbelt; Nathan P Wiederhold; Jacques Guillot
Journal:  Med Mycol       Date:  2018-04-01       Impact factor: 4.076

Review 4.  How Environmental Fungi Cause a Range of Clinical Outcomes in Susceptible Hosts.

Authors:  Steven T Denham; Morgan A Wambaugh; Jessica C S Brown
Journal:  J Mol Biol       Date:  2019-05-09       Impact factor: 5.469

Review 5.  Commensal Fungi in Health and Disease.

Authors:  Jose J Limon; Joseph H Skalski; David M Underhill
Journal:  Cell Host Microbe       Date:  2017-08-09       Impact factor: 21.023

6.  Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease.

Authors:  Christel Chehoud; Lindsey G Albenberg; Colleen Judge; Christian Hoffmann; Stephanie Grunberg; Kyle Bittinger; Robert N Baldassano; James D Lewis; Frederic D Bushman; Gary D Wu
Journal:  Inflamm Bowel Dis       Date:  2015-08       Impact factor: 5.325

Review 7.  Structure-guided approaches to targeting stress responses in human fungal pathogens.

Authors:  Emmanuelle V LeBlanc; Elizabeth J Polvi; Amanda O Veri; Gilbert G Privé; Leah E Cowen
Journal:  J Biol Chem       Date:  2020-08-12       Impact factor: 5.157

8.  Cathelicidin-inspired antimicrobial peptides as novel antifungal compounds.

Authors:  Martin van Eijk; Stephanie Boerefijn; Lida Cen; Marisela Rosa; Marnix J H Morren; Cornelis K van der Ent; Bart Kraak; Jan Dijksterhuis; Ivan D Valdes; Henk P Haagsman; Hans de Cock
Journal:  Med Mycol       Date:  2020-11-10       Impact factor: 4.076

Review 9.  The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives.

Authors:  Christophe d'Enfert; Ann-Kristin Kaune; Leovigildo-Rey Alaban; Sayoni Chakraborty; Nathaniel Cole; Margot Delavy; Daria Kosmala; Benoît Marsaux; Ricardo Fróis-Martins; Moran Morelli; Diletta Rosati; Marisa Valentine; Zixuan Xie; Yoan Emritloll; Peter A Warn; Frédéric Bequet; Marie-Elisabeth Bougnoux; Stephanie Bornes; Mark S Gresnigt; Bernhard Hube; Ilse D Jacobsen; Mélanie Legrand; Salomé Leibundgut-Landmann; Chaysavanh Manichanh; Carol A Munro; Mihai G Netea; Karla Queiroz; Karine Roget; Vincent Thomas; Claudia Thoral; Pieter Van den Abbeele; Alan W Walker; Alistair J P Brown
Journal:  FEMS Microbiol Rev       Date:  2021-05-05       Impact factor: 16.408

Review 10.  Inherited CARD9 Deficiency: Invasive Disease Caused by Ascomycete Fungi in Previously Healthy Children and Adults.

Authors:  Emilie Corvilain; Jean-Laurent Casanova; Anne Puel
Journal:  J Clin Immunol       Date:  2018-08-22       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.